Cargando…
Molecular pathology and clinical implications of diffuse glioma
The prognosis for diffusely infiltrating gliomas at World Health Organization (WHO) grade 2–4 remains dismal due to their heterogeneity. The rapid development of genome-wide molecular-profiling-associated studies has greatly promoted the accuracy of glioma classification. Thus, the latest version of...
Autores principales: | Chai, Ruichao, Fang, Shengyu, Pang, Bo, Liu, Yuqing, Wang, Yongzhi, Zhang, Wei, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106158/ https://www.ncbi.nlm.nih.gov/pubmed/36728558 http://dx.doi.org/10.1097/CM9.0000000000002446 |
Ejemplares similares
-
Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma
por: Zhou, Zhengui, et al.
Publicado: (2018) -
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
por: Zhang, Kenan, et al.
Publicado: (2022) -
Role of molecular biomarkers in glioma resection: a systematic review
por: Li, Lianwang, et al.
Publicado: (2020) -
Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
por: Zhang, Kenan, et al.
Publicado: (2023) -
Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations
por: Mo, Zongchao, et al.
Publicado: (2022)